Bostock E, Dingledine R, Xu G, Chang K J
J Pharmacol Exp Ther. 1984 Dec;231(3):512-7.
The effects of the opioid peptides morphiceptin and [N-MePhe3-D-Pro4]morphiceptin (PL017), both mu receptor agonists, were examined by electrophysiological techniques in the rat hippocampal slice and ligand binding techniques in hippocampal membrane preparations. The electrophysiological actions of the mu agonists were similar to those of the previously studied delta receptor agonist [D-Ala2, D-Leu5]enkephalin. Thus, for a given size field excitatory postsynaptic potential the amplitude of both population spike and intracellular excitatory postsynaptic potential was increased by morphiceptin. These effects were concentration dependent and reversed by naloxone. The EC50 for morphiceptin was 1.6 microM, which is consistent with the mu-selective binding properties of this peptide. Similar results were obtained with the more potent analog PL017. Morphiceptin and morphine had similar displacement profiles in competition experiments performed with hippocampal membranes and a variety of radioligands. In Tris buffer morphiceptin potently inhibited the binding of the mu receptor marker [125I]FK 33,824 but displayed the expected shallow displacement isotherm against binding of the delta receptor marker [125I][D-Ala2, D-Leu5]enkephalin. A significant interaction of either morphiceptin or morphine with kappa binding sites is improbable since neither agonist could fully displace binding of [3H]ethylketocyclazocine or [3H]diprenorphine. The potency of morphiceptin in displacing [3H]naloxone from mu binding sites was reduced by inclusion of 100 mM NaCl or 100 microM GTP in the assay. The dissociation constant of morphiceptin for mu binding sites in physiological saline was 0.78 microM, comparable to its EC50 determined in electrophysiological experiments. It appears, therefore, that the electrophysiological properties of opioid peptides in the hippocampal slice may be mediated by both mu and delta receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
采用电生理技术在大鼠海马脑片以及配体结合技术在海马膜制剂中,研究了阿片肽吗啡肽和[N-甲基苯丙氨酸3- D-脯氨酸4]吗啡肽(PL017)(二者均为μ受体激动剂)的作用。μ激动剂的电生理作用与先前研究的δ受体激动剂[D-丙氨酸2,D-亮氨酸5]脑啡肽相似。因此,对于给定大小的场兴奋性突触后电位,吗啡肽可增加群体峰电位和细胞内兴奋性突触后电位的幅度。这些作用呈浓度依赖性,且可被纳洛酮逆转。吗啡肽的EC50为1.6微摩尔,这与其μ选择性结合特性相符。用更强效的类似物PL017也得到了相似结果。在使用海马膜和多种放射性配体进行的竞争实验中,吗啡肽和吗啡具有相似的置换曲线。在Tris缓冲液中,吗啡肽能有效抑制μ受体标记物[125I]FK 33,824的结合,但对δ受体标记物[125I][D-丙氨酸2,D-亮氨酸5]脑啡肽的结合呈现预期的浅置换等温线。由于这两种激动剂都不能完全置换[3H]乙基酮环唑新或[3H]二丙诺啡的结合,所以吗啡肽或吗啡与κ结合位点发生显著相互作用的可能性不大。在测定中加入100 mM氯化钠或100微摩尔GTP会降低吗啡肽从μ结合位点置换[3H]纳洛酮的效力。吗啡肽在生理盐水中与μ结合位点的解离常数为0.78微摩尔,与其在电生理实验中测定的EC